{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T09:22:10Z","timestamp":1760865730613},"reference-count":25,"publisher":"Japan Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2012]]},"DOI":"10.1507\/endocrj.ej12-0047","type":"journal-article","created":{"date-parts":[[2012,6,4]],"date-time":"2012-06-04T13:53:22Z","timestamp":1338818002000},"page":"709-716","source":"Crossref","is-referenced-by-count":11,"title":["Evaluation of the effectiveness of sarpogrelate on the surrogate markers for macrovascular complications in patients with type 2 diabetes"],"prefix":"10.1507","volume":"59","author":[{"given":"So Young","family":"Park","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, Korea"},{"name":"Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Youl","family":"Rhee","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, Korea"},{"name":"Research Institute of Endocrinology, Kyung Hee University, Seoul, Korea"},{"name":"Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, Korea"},{"name":"Research Institute of Endocrinology, Kyung Hee University, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seungjoon","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, Korea"},{"name":"Research Institute of Endocrinology, Kyung Hee University, Seoul, Korea"},{"name":"Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, Korea"},{"name":"Research Institute of Endocrinology, Kyung Hee University, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyuk Sang","family":"Kwon","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea"},{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bong-Yun","family":"Cha","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea"},{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine, The Catholic University of Korea, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Joo","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine,Yonsei University College of Medicine, Seoul, Korea"},{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine,Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyun Chul","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine,Yonsei University College of Medicine, Seoul, Korea"},{"name":"Division of Endocrinology and Metabolism, Department of Internal Medicine,Yonsei University College of Medicine, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Seol","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, Korea"},{"name":"Research Institute of Endocrinology, Kyung Hee University, Seoul, Korea"},{"name":"Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, Korea"},{"name":"Research Institute of Endocrinology, Kyung Hee University, Seoul, Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1177\/107602960401000302"},{"key":"2","unstructured":"2. Santoso T (2006) Prevention of cardiovascular disease in diabetes mellitus: by stressing the CARDS study. <i>Acta Med Indones<\/i> 38: 97-102."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. American Diabetes Association (2011) Standards of medical care in diabetes--2011. <i>Diabetes Care<\/i> 34 Suppl 1: S11-61.","DOI":"10.2337\/dc11-S011"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1097\/01.mbc.0000176197.48134.08"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Hasegawa Y, Suehiro A, Higasa S, Namba M, Kakishita E (2002) Enhancing effect of advanced glycation end products on serotonin-induced platelet aggregation in patients with diabetes mellitus. <i>Thromb Res<\/i> 107: 319-323.","DOI":"10.1016\/S0049-3848(02)00348-1"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Pietraszek MH, Takada Y, Taminato A, Yoshimi T, Watanabe I, Takada A (1993) The effect of MCI-9042 on serotonin-induced platelet aggregation in type 2 diabetes mellitus. <i>Thromb Res<\/i> 70: 131-138.","DOI":"10.1016\/0049-3848(93)90154-G"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.107.505131"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Shinohara Y, Nishimaru K (2009) Sarpogrelate versus aspirin in secondary prevention of cerebral infarction: differential efficacy in diabetes? Subgroup analysis from S-ACCESS. <i>Stroke<\/i> 40: 2862-2865.","DOI":"10.1161\/STROKEAHA.109.554246"},{"key":"9","doi-asserted-by":"crossref","unstructured":"10. Shouzu A, Nomura S, Hayakawa T, Omoto S, Shimizu H, Miyake Y, Yonemoto T, Fukuhara S, Iwasaka T, Nishikawa M, Inada M (2000) Effect of sarpogrelate hydrochloride on platelet-derived microparticles and various soluble adhesion molecules in diabetes mellitus. <i>Clin Appl Thromb Hemost<\/i> 6: 139-143.","DOI":"10.1177\/107602960000600304"},{"key":"10","doi-asserted-by":"crossref","unstructured":"12. Yamakawa J, Takahashi T, Saegusa S, Moriya J, Itoh T, Kusaka K, Kawaura K, Wang XQ, Kanda T (2004) Effect of the serotonin blocker sarpogrelate on circulating interleukin-18 levels in patients with diabetes and arteriosclerosis obliterans. <i>J Int Med Res<\/i> 32: 166-169.","DOI":"10.1177\/147323000403200209"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.8.2477"},{"key":"12","doi-asserted-by":"crossref","unstructured":"14. Bir SC, Fujita M, Marui A, Hirose K, Arai Y, Sakaguchi H, Huang Y, Esaki J, Ikeda T, Tabata Y, Komeda M (2008) New therapeutic approach for impaired arteriogenesis in diabetic mouse hindlimb ischemia. <i>Circ J<\/i> 72: 633-640.","DOI":"10.1253\/circj.72.633"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-003-0750-3"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-007-0011-8"},{"key":"15","doi-asserted-by":"crossref","unstructured":"17. Ogawa S, Mori T, Nako K, Ishizuka T, Ito S (2008) Reduced albuminuria with sarpogrelate is accompanied by a decrease in monocyte chemoattractant protein-1 levels in type 2 diabetes. <i>Clin J Am Soc Nephrol<\/i> 3: 362-368.","DOI":"10.2215\/CJN.03450807"},{"key":"16","doi-asserted-by":"crossref","unstructured":"18. Takahashi T, Yano M, Minami J, Haraguchi T, Koga N, Higashi K, Kobori S (2002) Sarpogrelate hydrochloride, a serotonin2A receptor antagonist, reduces albuminuria in diabetic patients with early-stage diabetic nephropathy. <i>Diabetes Res Clin Pract<\/i> 58: 123-129.","DOI":"10.1016\/S0168-8227(02)00105-5"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-200402000-00015"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)64912-9"},{"key":"19","doi-asserted-by":"crossref","unstructured":"22. Weber R, Diener HC (2010) Controversies and future perspectives of antiplatelet therapy in secondary stroke prevention. <i>J Cell Mol Med<\/i> 14: 2371-2380.","DOI":"10.1111\/j.1582-4934.2010.01162.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"24. Polak JF, Pencina MJ, Meisner A, Pencina KM, Brown LS, Wolf PA, D&rsquo;Agostino RB, Sr. (2010) Associations of carotid artery intima-media thickness (IMT) with risk factors and prevalent cardiovascular disease: comparison of mean common carotid artery IMT with maximum internal carotid artery IMT. <i>J Ultrasound Med<\/i> 29: 1759-1768.","DOI":"10.7863\/jum.2010.29.12.1759"},{"key":"21","unstructured":"25. Kablak-Ziembicka A, Przewlocki T, Stepien E, Pieniazek P, Rzeznik D, Sliwiak D, Komar M, Tracz W, Podolec P (2011) Relationship between carotid intima-media thickness, cytokines, atherosclerosis extent and a two-year cardiovascular risk in patients with arteriosclerosis. <i>Kardiol Pol<\/i> 69: 1024-1031."},{"key":"22","doi-asserted-by":"crossref","unstructured":"26. Gudbjornsdottir S, Eeg-Olofsson K, Cederholm J, Zethelius B, Eliasson B, Nilsson PM (2009) Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR). <i>Diabet Med<\/i> 26: 53-60.","DOI":"10.1111\/j.1464-5491.2008.02633.x"},{"key":"23","doi-asserted-by":"crossref","unstructured":"27. Sonecha TN, Henein MY (2005) The role of intima-medial thickness (IMT) in clinical cardiovascular practice. <i>Int J Cardiovasc Imaging<\/i> 21: 505-507.","DOI":"10.1007\/s10554-005-0507-9"},{"key":"24","unstructured":"28. Suslina ZA, Tanashian MM, Domashenko MA (2011) Resistance to antiplatelet drugs in patients with cerebrovascular disorders. <i>Vestn Ross Akad Med Nauk <\/i>(7): 3-8 (In Russian)."},{"key":"25","doi-asserted-by":"crossref","unstructured":"29. Levi M, Eerenberg E, Kamphuisen PW (2011) Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. <i>J Thromb Haemost<\/i> 9: 1705-1712.","DOI":"10.1111\/j.1538-7836.2011.04432.x"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/59\/8\/59_EJ12-0047\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,13]],"date-time":"2021-04-13T06:28:37Z","timestamp":1618295317000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/59\/8\/59_EJ12-0047\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej12-0047","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012]]}}}